stat-flex software program version 6 (ARTEC CO LTD)
90
Structured Review
ARTEC CO LTD
stat-flex software program version 6
Stat Flex Software Program Version 6, supplied by ARTEC CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stat+flex+software+program/stat+flex+version+6+0/pmc12097842-53-2-5
Average 90 stars, based on 1 article reviews
Stat Flex Software Program Version 6, supplied by ARTEC CO LTD, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/stat+flex+software+program/stat+flex+version+6+0/pmc12097842-53-2-5
Average 90 stars, based on 1 article reviews
stat-flex software program version 6 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Mann-Whitney U-Test:Article Title: Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic Article Snippet: Trend analyses of the prevalence of MASLD, LRDs, obesity, HWC, dietary nutrient intake, and MASLD were performed using Spearman’s rank correlation, and comparisons between MASLD and non-MASLD were performed by the Chi-square and Student’s t -test with Stat Flex, Article Title: Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis. Article Snippet: All statistical analyses were performed using the Stat-Flex software Article Title: A Low Level of High-Density Lipoprotein Cholesterol Predicts All-Cause Mortality Within 30 Days in Hospitalized Elderly Patients Article Snippet: Stat-Flex software Article Title: Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies. Article Snippet: Tumor cells possess a mechanism to escape from tumor immunity by inhibiting immune cell activation via the PD1 (programmed cell death 1 protein)/PDL1 (programmed cell death ligand 1) axis.1 The binding of PDL1 to PD1 on T cells induces inhibitory signals, modulating the response of T cells against tumor cells.1 Immune checkpoint inhibitors (ICIs) targeting PD1/PDL1 interaction have demonstrated significant improvement of prognosis in a wide range of patients with cancer.2 However, the efficacy of PD1 blockade is limited to a small portion of the patients, with the objective response rate accounting for 29% of melanoma cases, 27% of lung cancer cases, and 11% of breast cancer cases.2 In addition, ICIs can cause an adverse reaction distinct from that of conventional anticancer drugs.. This adverse reaction is characterized by an unregulated immune response against selftissues, resulting in a spectrum of side effects called immunerelated adverse events (irAEs). irAEs develop in approximately 21% to 59% of patients after ICI treatment,3 and this may lead to cessation of additional ICI treatments.3–5 In addition, some fatal cases with irAEs have also been reported.3,6 Therefore, it is necessary to develop Received: 1 December 2023 | Accepted: 19 February 2024 DOI: 10.1111/1346-8138.17183 Article Title: Enhanced Hypercoagulability Using Clot Waveform Analysis in Patients with Acute Myocardial Infarction and Acute Cerebral Infarction. Article Snippet: All statistical analyses were performed using the Stat-Flex software Article Title: Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation. Article Snippet: All statistical analyses were performed with IBM SPSS Statistics version 21.0 (IBM, Tokyo, Japan), Stat Flex Article Title: The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate. Article Snippet: All statistical analyses were performed using the Software:Article Title: Metabolic Dysfunction-Associated Steatotic Liver Disease in Japan: Prevalence Trends and Clinical Background in the 10 Years before the Coronavirus Disease 2019 Pandemic Article Snippet: Trend analyses of the prevalence of MASLD, LRDs, obesity, HWC, dietary nutrient intake, and MASLD were performed using Spearman’s rank correlation, and comparisons between MASLD and non-MASLD were performed by the Chi-square and Student’s t -test with Stat Flex, Article Title: Detection of a Prethrombotic State in Patients with Hepatocellular Carcinoma, Using a Clot Waveform Analysis. Article Snippet: All statistical analyses were performed using the Stat-Flex software Article Title: A Low Level of High-Density Lipoprotein Cholesterol Predicts All-Cause Mortality Within 30 Days in Hospitalized Elderly Patients Article Snippet: Stat-Flex software Article Title: Soluble PD-L1 predicts tumor response and immune-related adverse events in patients with advanced melanoma treated with anti-PD-1 antibodies. Article Snippet: Tumor cells possess a mechanism to escape from tumor immunity by inhibiting immune cell activation via the PD1 (programmed cell death 1 protein)/PDL1 (programmed cell death ligand 1) axis.1 The binding of PDL1 to PD1 on T cells induces inhibitory signals, modulating the response of T cells against tumor cells.1 Immune checkpoint inhibitors (ICIs) targeting PD1/PDL1 interaction have demonstrated significant improvement of prognosis in a wide range of patients with cancer.2 However, the efficacy of PD1 blockade is limited to a small portion of the patients, with the objective response rate accounting for 29% of melanoma cases, 27% of lung cancer cases, and 11% of breast cancer cases.2 In addition, ICIs can cause an adverse reaction distinct from that of conventional anticancer drugs.. This adverse reaction is characterized by an unregulated immune response against selftissues, resulting in a spectrum of side effects called immunerelated adverse events (irAEs). irAEs develop in approximately 21% to 59% of patients after ICI treatment,3 and this may lead to cessation of additional ICI treatments.3–5 In addition, some fatal cases with irAEs have also been reported.3,6 Therefore, it is necessary to develop Received: 1 December 2023 | Accepted: 19 February 2024 DOI: 10.1111/1346-8138.17183 Article Title: Enhanced Hypercoagulability Using Clot Waveform Analysis in Patients with Acute Myocardial Infarction and Acute Cerebral Infarction. Article Snippet: All statistical analyses were performed using the Stat-Flex software Article Title: Clinical usefulness of urinary biomarkers for early prediction of acute kidney injury in patients undergoing transaortic valve implantation. Article Snippet: All statistical analyses were performed with IBM SPSS Statistics version 21.0 (IBM, Tokyo, Japan), Stat Flex Article Title: The Evaluation of Clot Waveform Analyses for Assessing Hypercoagulability in Patients Treated with Factor VIII Concentrate. Article Snippet: All statistical analyses were performed using the |